TT virus infection in patients on peritoneal dialysis in Taiwan

Bang Gee Hsu, Li Yu Wang, Chi Tan Hu, Chih Hsien Wang, Te Chao Fang, Hans Hsienhong Lin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Many studies have reported the prevalence of transfusion-transmitted virus (TTV) infection in hemodialysis patients, but few reports studied the prevalence of TTV infection in peritoneal dialysis patients. In this study, we determined the prevalence of TTV in a peritoneal dialysis population in Taiwan and related its prevalence with history of blood transfusion, serum hepatitis B surface antigen (HBsAg), antibody to hepatitis C virus (anti-HCV), and serum aminotransferases (AST and ALT) levels. Serum samples from 47 peritoneal dialysis patients and a control group of 43 patients at health examination were studied for TTV viremia by using polymerase chain reaction. The rate of blood transfusion exposure (p <0.0001), female gender (p = 0.001), younger age (p = 0.0014), and serum AST level (p = 0.012) were significantly higher in peritoneal dialysis patients. The prevalence of TTV viremia was not significantly different between peritoneal dialysis patients and the control group (23.4% vs. 37.2%). TTV infection was not associated with evident liver diseases in peritoneal dialysis patients, and the infection rate was not different between automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients. There was no statistically significant association between TTV infection and age, gender, transfusion history, duration of peritoneal dialysis, AST level, ALT level, HBsAg, or anti-HCV seropositivity in peritoneal dialysis patients. Our results suggest that TTV infection is not associated with evident liver diseases, and there is no difference between TTV infection in healthy individuals and peritoneal dialysis patients. TTV transmission probably occurs via routes unrelated to peritoneal dialysis.

Original languageEnglish
Pages (from-to)553-557
Number of pages5
JournalRenal Failure
Volume29
Issue number5
DOIs
Publication statusPublished - Jun 2007
Externally publishedYes

Fingerprint

Torque teno virus
Peritoneal Dialysis
Virus Diseases
Taiwan
Viremia
Hepatitis B Surface Antigens
Serum
Blood Transfusion
Liver Diseases
Hepatitis B Antibodies
Control Groups
Hepatitis C Antibodies
Continuous Ambulatory Peritoneal Dialysis
Transaminases
Hepacivirus
Renal Dialysis

Keywords

  • Peritoneal dialysis
  • Prevalence
  • Transfusion-transmitted virus (TTV)

ASJC Scopus subject areas

  • Nephrology

Cite this

Hsu, B. G., Wang, L. Y., Hu, C. T., Wang, C. H., Fang, T. C., & Lin, H. H. (2007). TT virus infection in patients on peritoneal dialysis in Taiwan. Renal Failure, 29(5), 553-557. https://doi.org/10.1080/08860220701392074

TT virus infection in patients on peritoneal dialysis in Taiwan. / Hsu, Bang Gee; Wang, Li Yu; Hu, Chi Tan; Wang, Chih Hsien; Fang, Te Chao; Lin, Hans Hsienhong.

In: Renal Failure, Vol. 29, No. 5, 06.2007, p. 553-557.

Research output: Contribution to journalArticle

Hsu, BG, Wang, LY, Hu, CT, Wang, CH, Fang, TC & Lin, HH 2007, 'TT virus infection in patients on peritoneal dialysis in Taiwan', Renal Failure, vol. 29, no. 5, pp. 553-557. https://doi.org/10.1080/08860220701392074
Hsu, Bang Gee ; Wang, Li Yu ; Hu, Chi Tan ; Wang, Chih Hsien ; Fang, Te Chao ; Lin, Hans Hsienhong. / TT virus infection in patients on peritoneal dialysis in Taiwan. In: Renal Failure. 2007 ; Vol. 29, No. 5. pp. 553-557.
@article{b534c244458c47e3899c5f9596322bcd,
title = "TT virus infection in patients on peritoneal dialysis in Taiwan",
abstract = "Many studies have reported the prevalence of transfusion-transmitted virus (TTV) infection in hemodialysis patients, but few reports studied the prevalence of TTV infection in peritoneal dialysis patients. In this study, we determined the prevalence of TTV in a peritoneal dialysis population in Taiwan and related its prevalence with history of blood transfusion, serum hepatitis B surface antigen (HBsAg), antibody to hepatitis C virus (anti-HCV), and serum aminotransferases (AST and ALT) levels. Serum samples from 47 peritoneal dialysis patients and a control group of 43 patients at health examination were studied for TTV viremia by using polymerase chain reaction. The rate of blood transfusion exposure (p <0.0001), female gender (p = 0.001), younger age (p = 0.0014), and serum AST level (p = 0.012) were significantly higher in peritoneal dialysis patients. The prevalence of TTV viremia was not significantly different between peritoneal dialysis patients and the control group (23.4{\%} vs. 37.2{\%}). TTV infection was not associated with evident liver diseases in peritoneal dialysis patients, and the infection rate was not different between automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients. There was no statistically significant association between TTV infection and age, gender, transfusion history, duration of peritoneal dialysis, AST level, ALT level, HBsAg, or anti-HCV seropositivity in peritoneal dialysis patients. Our results suggest that TTV infection is not associated with evident liver diseases, and there is no difference between TTV infection in healthy individuals and peritoneal dialysis patients. TTV transmission probably occurs via routes unrelated to peritoneal dialysis.",
keywords = "Peritoneal dialysis, Prevalence, Transfusion-transmitted virus (TTV)",
author = "Hsu, {Bang Gee} and Wang, {Li Yu} and Hu, {Chi Tan} and Wang, {Chih Hsien} and Fang, {Te Chao} and Lin, {Hans Hsienhong}",
year = "2007",
month = "6",
doi = "10.1080/08860220701392074",
language = "English",
volume = "29",
pages = "553--557",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - TT virus infection in patients on peritoneal dialysis in Taiwan

AU - Hsu, Bang Gee

AU - Wang, Li Yu

AU - Hu, Chi Tan

AU - Wang, Chih Hsien

AU - Fang, Te Chao

AU - Lin, Hans Hsienhong

PY - 2007/6

Y1 - 2007/6

N2 - Many studies have reported the prevalence of transfusion-transmitted virus (TTV) infection in hemodialysis patients, but few reports studied the prevalence of TTV infection in peritoneal dialysis patients. In this study, we determined the prevalence of TTV in a peritoneal dialysis population in Taiwan and related its prevalence with history of blood transfusion, serum hepatitis B surface antigen (HBsAg), antibody to hepatitis C virus (anti-HCV), and serum aminotransferases (AST and ALT) levels. Serum samples from 47 peritoneal dialysis patients and a control group of 43 patients at health examination were studied for TTV viremia by using polymerase chain reaction. The rate of blood transfusion exposure (p <0.0001), female gender (p = 0.001), younger age (p = 0.0014), and serum AST level (p = 0.012) were significantly higher in peritoneal dialysis patients. The prevalence of TTV viremia was not significantly different between peritoneal dialysis patients and the control group (23.4% vs. 37.2%). TTV infection was not associated with evident liver diseases in peritoneal dialysis patients, and the infection rate was not different between automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients. There was no statistically significant association between TTV infection and age, gender, transfusion history, duration of peritoneal dialysis, AST level, ALT level, HBsAg, or anti-HCV seropositivity in peritoneal dialysis patients. Our results suggest that TTV infection is not associated with evident liver diseases, and there is no difference between TTV infection in healthy individuals and peritoneal dialysis patients. TTV transmission probably occurs via routes unrelated to peritoneal dialysis.

AB - Many studies have reported the prevalence of transfusion-transmitted virus (TTV) infection in hemodialysis patients, but few reports studied the prevalence of TTV infection in peritoneal dialysis patients. In this study, we determined the prevalence of TTV in a peritoneal dialysis population in Taiwan and related its prevalence with history of blood transfusion, serum hepatitis B surface antigen (HBsAg), antibody to hepatitis C virus (anti-HCV), and serum aminotransferases (AST and ALT) levels. Serum samples from 47 peritoneal dialysis patients and a control group of 43 patients at health examination were studied for TTV viremia by using polymerase chain reaction. The rate of blood transfusion exposure (p <0.0001), female gender (p = 0.001), younger age (p = 0.0014), and serum AST level (p = 0.012) were significantly higher in peritoneal dialysis patients. The prevalence of TTV viremia was not significantly different between peritoneal dialysis patients and the control group (23.4% vs. 37.2%). TTV infection was not associated with evident liver diseases in peritoneal dialysis patients, and the infection rate was not different between automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients. There was no statistically significant association between TTV infection and age, gender, transfusion history, duration of peritoneal dialysis, AST level, ALT level, HBsAg, or anti-HCV seropositivity in peritoneal dialysis patients. Our results suggest that TTV infection is not associated with evident liver diseases, and there is no difference between TTV infection in healthy individuals and peritoneal dialysis patients. TTV transmission probably occurs via routes unrelated to peritoneal dialysis.

KW - Peritoneal dialysis

KW - Prevalence

KW - Transfusion-transmitted virus (TTV)

UR - http://www.scopus.com/inward/record.url?scp=34547215893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547215893&partnerID=8YFLogxK

U2 - 10.1080/08860220701392074

DO - 10.1080/08860220701392074

M3 - Article

C2 - 17654317

AN - SCOPUS:34547215893

VL - 29

SP - 553

EP - 557

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 5

ER -